Mapping EQ-5D utility scores from the incontinence quality of life questionnaire among patients with neurogenic and idiopathic overactive bladder

Value in Health

Volumn 16, Issue 2, 2013, Pages 394-402

  Kay, Stephen ^a   Tolley, Keith ^b   Colayco, Danielle ^c   Khalaf, Kristin ^c   Anderson, Peter ^a   Globe, Denise ^c  

^a ADELPHI REAL WORLD   (United Kingdom)

^b Tolley Health Economics Ltd   (United Kingdom)

^c ALLERGAN INC   (United States)

Author keywords

cross walk; EQ 5D; I QOL; mapping; real world; utility values

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CALCULATION; COST EFFECTIVENESS ANALYSIS; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL MODEL; UNITED STATES;

CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; SPAIN; UNITED STATES; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 84875418633     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.12.005     Document Type: Article

References (46)

1. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
2. G.W. Torrance Measurement of health state utilities for economic appraisal J Health Econ 5 1986 1 30
3. A. Szende, and C. Schaefer A taxonomy of health utility assessment methods and the role for uncertainty analysis Eur J Health Econ 7 2006 147 151
4. I. McDowell, and C. Newell Measuring Health: A Guide to Rating Scales and Questionnaires 2nd ed. 1996 Oxford University Press New York
5. N.P. Hurst, P. Kind, and D. Ruta Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) Br J Rheumatol 36 1997 551 559
6. J. Brazier, N. Jones, and P. Kind Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire Qual Life Res 2 1993 169 180
7. P. Kind, G. Hardman, and S. Macran UK population norms for EQ-5D. York Centre for Health Economics, Discussion Paper University of York 1999
8. J.W. Shaw, J.A. Johnson, and S.J. Coons US valuation of the EQ-5D health states: development and testing of the D1 valuation model Med Care 43 2005 203 220
9. M. Herdman, C. Gudex, and A. Lloyd Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res 20 2011 1727 1736
10. P. Abrams, L. Cardozo, and M. Fall The standardisation of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178
11. P. Milsom, P. Abrams, and L. Cardozo How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 2001 760 766
12. W.F. Stewart, J.B. Van Rooyen, and G.W. Cundiff Prevalence and burden of overactive bladder in the United States World J Urol 20 2003 327 336
13. D.E. Irwin, I. Milsom, and S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306 1314
14. S. Herschorn, J. Gajewski, J. Schultz, and J. Corcos A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey BJU Int 101 2007 52 58
15. P. Abrams, C.J. Kelleher, L.A. Kerr, and R.G. Rogers Overactive bladder significantly affects quality of life Am J Manag Care 6 2000 S580 S590
16. A. Tubaro Defining overactive bladder: epidemiology and burden of disease Urology 64 Suppl 2004 S2 S6
17. K.S. Coyne, C. Payne, and S.K. Bhattacharyya The impact of urinary urgency and frequency on health-related qualify of life in overactive bladder: results from a national survey Value Health 7 2004 455 463
18. D. Irwin, I. Milsom, and Z. Kopp Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries BJU Int 97 2006 96 100
19. B.H. Zorn, H. Montgomery, and K. Pieper Urinary incontinence and depression J Urol 162 1999 82 84
20. P.A. Norton, N.R. Zinner, I. Yalcin, and R.C. Bump Duloxetine versus placebo in the treatment of stress urinary incontinence Am J Obstet Gynaecol 187 2002 40 48
21. R.R. Dmochowski, J.R. Miklos, and P.A. Norton Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence J Urol 170 2003 1259 1263
22. R.J. Millard, K. Moore, and R. Rencken Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial BJU Int 93 2004 311 318
23. P. van Kerrebroeck, P. Abrams, and R. Lange Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence BJOG 111 2004 249 257
24. D.L. Patrick, M.L. Martin, and D.M. Bushnell The I-QOL: A Quality-of-Life Instrument Specific to Persons with Urinary Incontinence: User's Manual and Scoring Diskette for United States Version 1999 Health Research Associates, Inc Seattle, WA
25. T.H. Wagner, D.L. Patrick, and T.G. Bavendam Quality of life of persons with urinary incontinence: development of a new measure Urology 47 1996 67 71
26. D.L. Patrick, M.L. Martin, and D.M. Bushnell Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL) Urology 53 1999 71 76
27. D.L. Patrick, M.L. Martin, and D.M. Bushnell Cultural adaptation of a quality-of-life measure for urinary incontinence Eur Urol 36 1999 427 435
28. D.M. Bushnell, M.L. Martin, and K.H. Summers Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL Qual Life Res 14 2005 1901 1913
29. B. Schurch, P. Denys, and C.M. Kozma Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence Arch Phys Med Rehabil 88 2007 646 652
30. P. Anderson, M. Benford, and N. Harris Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand Curr Med Res Opin 24 2008 3063 3072
31. National Institute for Health and Clinical Excellence. Submission to the Kennedy Review April 3, 2009. Available from: http://www.nice.org.uk/media/B4F/ 7F/KennedyPHE.pdf. [Accessed October 2, 2012].
32. P.W. Sullivan, and V. Ghushchyan Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample Med Decis Making 26 2006 401 409
33. J. Mullahy Much ado about two: reconsidering retransformation and the two-part model in health econometrics J Health Econ 17 1998 247 281
34. W. Sauerbrei, C. Meier-Hirmer, A. Benner, and P. Royston Multivariable regression model building by using fractional polynomials: description of SAS, STATA and R programs Comput Stat Data Anal 50 2006 3464 3485
35. P. Royston, and W. Sauerbrei Multivariable Model-Building 2008 Wiley New York
36. G.G. Judge, R.C. Hill, and W.E. Griffiths Introduction to the Theory and Practice of Econometrics 2nd ed. 1988 Wiley New York
37. W. Greene Econometric Analysis 2nd ed. 1993 Prentice-Hall Englewood Cliffs, NJ
38. N. Kontodimopoulos, V.H. Aletras, D. Paliouras, and D. Niakas Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments Value Health 12 2009 1151 1157
39. R. Crott, and A. Briggs Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences Eur J Health Econ 11 2010 427 434
40. A.S. Pickard, S. Ray, A. Ganguli, and D. Cella Comparison of FACT- and EQ-5D-based utility scores in cancer Value Health 15 2012 305 311
41. F. Xie, E.M. Pullenayegum, and S.C. Li Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index Value Health 13 2010 873 878
42. H.J. Starkie, A.H. Briggs, M.G. Chambers, and P. Jones Predicting EQ-5D values using the SGRQ Value Health 14 2011 354 360
43. Y. Yang, J. Brazier, A. Tsuchiya, and K. Coyne Estimating a preference-based single index from the Overactive Bladder Questionnaire Value Health 12 2009 159 166
44. J. Brazier, Y. Yang, A. Tsuchiya, and D.L. Rowen A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
45. J. Tosh, L. Longworth, and E. George Utility values in NICE technology appraisals Value Health 14 2011 102 109
46. Longworth L, Rowen DL. NICE DSU Technical Support Document 10: the use of mapping methods to estimate health state utility values. 2011. Available from: http://www.nicesdu.or.uk. [Accessed March 19, 2012].